KFLG logo

Kemofarmacija d. d LJSE:KFLG Stock Report

Last Price

€79.00

Market Cap

€69.6m

7D

0%

1Y

n/a

Updated

06 Aug, 2023

Data

Company Financials

KFLG Stock Overview

Kemofarmacija d. d. engages in the wholesale distribution of medicinal products and medical devices to healthcare systems, pharmacies, and hospitals in Slovenia.

KFLG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Kemofarmacija d. d. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kemofarmacija d. d
Historical stock prices
Current Share Price€79.00
52 Week High€79.00
52 Week Low€52.00
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO255.86%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

KFLGSI HealthcareSI Market
7D0%1.0%-0.2%
1Yn/a-7.3%15.1%

Return vs Industry: Insufficient data to determine how KFLG performed against the SI Healthcare industry.

Return vs Market: Insufficient data to determine how KFLG performed against the SI Market.

Price Volatility

Is KFLG's price volatile compared to industry and market?
KFLG volatility
KFLG Average Weekly Movementn/a
Healthcare Industry Average Movement4.9%
Market Average Movement3.0%
10% most volatile stocks in SI Market5.3%
10% least volatile stocks in SI Market2.2%

Stable Share Price: KFLG has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine KFLG's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1947n/aDavorin Pohercwww.kemofarmacija.si

Kemofarmacija d. d. engages in the wholesale distribution of medicinal products and medical devices to healthcare systems, pharmacies, and hospitals in Slovenia. It offers food supplements, cosmetic products, chemicals, and other services for pharmacies. The company also provides services for the import of unregistered medicines, logistical support in implementation of clinical trials, and warehousing and logistics.

Kemofarmacija d. d. Fundamentals Summary

How do Kemofarmacija d. d's earnings and revenue compare to its market cap?
KFLG fundamental statistics
Market cap€69.62m
Earnings (TTM)€0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KFLG income statement (TTM)
Revenue€0
Cost of Revenue€0
Gross Profit€0
Other Expenses€0
Earnings€0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did KFLG perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.